| Added by | mollevi |
|---|---|
| Group name | EquipeCG |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Department of Cancer Medicine, Institut Gustave Roussy, Villejuif. alt-title: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO number: 5 accession-num: 24595454 |
| Tags | _EndnoteXML import |
| Date Added | 2018/07/20 - 10:05:58 |
| Date Modified | 2018/07/20 - 10:05:58 |
| Parent item | Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial |
Institut de Recherche en Cancérologie de
